Date: 2015-12-24
Type of information: Resignation
Compound:
Company: Galena Biopharma (USA - OR)
Therapeutic area: Cancer - Oncology
Type agreement: resignation
Action mechanism:
Disease:
Details: * On December 24, 2015, Galena Biopharma announced that Steven A. Kriegsman has decided to retire as a Director of the Company when his current term expires the day prior to the June 2016 Annual Meeting of Stockholders. Mr. Kriegsman has served as a Class III Director since 2006 and was a member and chairman of several committees during his tenure. Galena will commence a search for his replacement.
Financial terms:
Latest news:
